Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 25, 2017
Sir Andrew Witty, CEO, GlaxoSmithKline shares his thoughts on the investment opportunities within the UK Life Sciences industry. Sir Andrew explains why now is the time to be investing in Life Sciences in the UK.